Respiratory Syncytial Virus (RSV) is estimated to affect 64 million people and claim around 160 000 lives around the world every year. Infants are most vulnerable and there is no effective treatment or vaccine. Tiyese Jeranji asks what we know about RSV in South Africa.
Access to pain management for infants and children in South Africa is inequitable, inconsistent and poorly resourced, resulting in unnecessary and avoidable suffering. Elsabé Brits investigates the state of paediatric pain management in South Africa and asks what can be done to bring pain relief to more infants and children.
The number of newborn babies dying from neonatal sepsis is rising as the antibiotics used to treat them are not working effectively, a landmark international study has found. Adele Baleta reports on the findings and their implications for newborns in South Africa.
A rise in teenage pregnancies and gender-based violence coupled with the loss and uncertainty related to COVID-19 are all stressors fuelling the mental health burden the pandemic will leave on children, especially girls. If not adequately addressed, argues Kholofelo Mphahlele, the mental health consequences for a generation of children and young people could far surpass the immediate health and economic impact of the COVID-19 pandemic, leaving harmful long-term social and economic consequences in its wake.
Early in South Africa’s fourth COVID-19 wave, dominated by the Omicron variant, concerns were raised on what appeared to be an increase in hospitalisations among children. A few months on, Elri Voigt asks local experts what we have learnt about the Omicron variant in children.
Findings from a study conducted in Mqanduli in the Eastern Cape show the prevalence of stunting among children younger than five for that area was 24%. Luvuyo Mehlwana unpacks the findings and the plans the provincial health department has in place to address the risk factors driving stunting among children in the Eastern Cape.
Children living with HIV have to take multiple different antiretroviral pills or syrups twice a day, while most adults in South Africa have been offered one pill once a day regimens for around a decade. At the recent South African HIV Clinicians Society (SAHCS) conference, various speakers argued that better treatment regimens for kids are needed urgently. Thabo Molelekwa reports.
Outbreaks of hospital-acquired infections such as Klebsiella have claimed the lives of infants and made headlines on a number of occasions over the last decade. Tiyese Jeranji looks at how the germs involved spread, how common these infections are, and what can be done to prevent outbreaks.
Following a decline in childhood immunisations during the COVID-19 hard lockdown last year, a nationwide catch-up drive was launched in November. Government is not sharing all the data on how the drive is going, but the data that we have been able to access shows that some important catch-up targets are being missed.
It has been over a year since the world saw the first confirmed case of COVID-19, yet the science behind the virus’ physical impact on children remains relatively unclear. Kathryn Cleary spoke to two experts in paediatrics and immunology to get an update on what we have learnt so far.
As the final negotiations in the 2021 budget process unfold, the government of the Eastern Cape and the department of health in particular are being asked to do more with less. It is now more urgent than ever to strengthen public primary health care, argue Ektaa Deochand and Russell Rensburg.
HIV medicines for children often taste bitter, pills are large, and for many children there is a lot of medication to take. This makes it hard to take treatment as prescribed. Tiyese Jeranji looks at the challenges with currently available HIV medicines for children, what innovations are in the pipeline, and how HIV treatment is being tailored to suit the needs of children.
